Sagimet Biosciences Inc. (SGMT) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2M | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | -100% | - | - | - | - | - | - | - |
| Cost of Goods Sold | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2M | 0 | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | 100% | - | - | - |
| Gross Profit Growth % | - | - | - | - | - | - | -100% | - | - | - | - | - | - | - |
| Operating Expenses | 11.71M | 10.77M | 14.33M | 11.93M | 19.86M | 18.2M | 16.9M | 10.59M | 8.77M | 9.47M | 9.45M | 7.06M | 6.76M | 7.39M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | 472.6% | - | - | - |
| Selling, General & Admin | 4.72M | 4.03M | 4.6M | 4.68M | 4.52M | 3.98M | 4.25M | 4.28M | 3.51M | 3.81M | 4.49M | 2.38M | 2.28M | 1.54M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | 224.7% | - | - | - |
| Research & Development | 7M | 6.73M | 9.73M | 7.25M | 15.34M | 14.22M | 12.65M | 6.31M | 5.26M | 5.66M | 4.96M | 4.68M | 4.49M | 5.85M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | 247.9% | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -11.71M | -10.77M | -14.33M | -11.93M | -19.86M | -18.2M | -16.9M | -10.59M | -8.77M | -9.47M | -7.45M | -7.06M | -6.76M | -7.39M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | -372.6% | - | - | - |
| Operating Income Growth % | 41.04% | 40.84% | 15.19% | -12.62% | -126.56% | -92.21% | -126.81% | -50.05% | -29.61% | -28.13% | - | - | - | - |
| EBITDA | -11.71M | -12.19M | -12.91M | -11.93M | -19.86M | -16.2M | -16.9M | -10.59M | 0 | 0 | -7.45M | -7.06M | -6.76M | 0 |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | -372.6% | - | - | - |
| EBITDA Growth % | 41.04% | 24.75% | 23.63% | -12.62% | - | - | -126.81% | -50.05% | 100% | - | - | - | - | - |
| D&A (Non-Cash Add-back) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8.77M | 9.47M | 0 | 0 | 0 | 7.39M |
| EBIT | -11.71M | -12.19M | -12.91M | -11.93M | -19.86M | -16.2M | -16.9M | -10.59M | -8.77M | -9.47M | -7.45M | -7.06M | -6.76M | -7.39M |
| Net Interest Income | 0 | -3.23M | 0 | 1.54M | 1.69M | 1.99M | 2.28M | 2.47M | 2.14M | 1.31M | 1.09M | 272K | 180K | 193K |
| Interest Income | 0 | -3.23M | 0 | 1.54M | 1.69M | 1.99M | 2.28M | 2.47M | 2.14M | 1.31M | 1.09M | 271K | 180K | 193K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 1.06M | 1.2M | 1.43M | 1.54M | 1.69M | 1.99M | 2.28M | 2.47M | 2.14M | 1.31M | 1.1M | 272K | 178K | 193K |
| Pretax Income | -10.65M | -9.57M | -12.91M | -10.39M | -18.18M | -16.2M | -14.62M | -8.12M | -6.63M | -8.15M | -6.35M | -6.79M | -6.59M | -7.2M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | -317.65% | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -10.65M | -9.57M | -12.91M | -10.39M | -18.18M | -16.2M | -14.62M | -8.12M | -6.63M | -8.15M | -6.35M | -6.79M | -6.59M | -7.2M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | -317.65% | - | - | - |
| Net Income Growth % | 41.41% | 40.94% | 11.7% | -27.94% | -174.19% | -98.76% | -130.11% | -19.65% | -0.64% | -13.29% | - | - | - | - |
| Net Income (Continuing) | -10.65M | -9.57M | -12.91M | -10.39M | -18.18M | -16.2M | -14.62M | -8.12M | -6.63M | -8.15M | -6.35M | -6.79M | -6.59M | -7.2M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.33 | -0.30 | -0.40 | -0.32 | -0.56 | -0.50 | -0.45 | -0.25 | -0.23 | -0.45 | -0.35 | -0.31 | -0.30 | -0.32 |
| EPS Growth % | 41.07% | 40% | 11.11% | -28% | -143.48% | -11.11% | -28.57% | 19.35% | 23.33% | -40.63% | - | - | - | - |
| EPS (Basic) | -0.33 | -0.30 | -0.40 | -0.32 | -0.56 | -0.50 | -0.45 | -0.25 | -0.23 | -0.45 | -0.35 | -0.31 | -0.30 | -0.32 |
| Diluted Shares Outstanding | 32.56M | 32.35M | 32.46M | 32.2M | 32.2M | 32.2M | 32.14M | 31.91M | 29.04M | 18.19M | 18.19M | 22.17M | 22.17M | 22.17M |
| Basic Shares Outstanding | 32.56M | 32.35M | 32.46M | 32.2M | 32.2M | 32.2M | 32.14M | 31.91M | 29.04M | 18.19M | 18.19M | 22.17M | 22.17M | 22.17M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - |